Literature DB >> 6908998

Deficient activity of the alternative pathway of complement in beta thalassemia major.

J M Corry, W C Marshall, L A Guthrie, A G Peerless, R B Johnston.   

Abstract

Patients with thalassemia major suffer frequent and serious infections, especially after splenectomy. To explore the basis for this susceptibility, we examined activity of the complement system in sera from 24 patients. All sera had normal or increased activity of the classic complement pathway. However, six of the 24 (three with and three without splenectomy) had abnormal alternative pathway function, and mean alternative pathway activity was significantly decreased in both splenectomized and nonsplenectomized patients. Mean concentrations of C3, factor B, properdin, and immunoglobulins were normal. Defective alternative pathway function, especially in conjunction with asplenia, could contribute to the propensity to infection that exists in thalassemia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6908998     DOI: 10.1001/archpedi.1981.02130300029011

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  6 in total

1.  Serum immunoglobulins, IgG subclasses, isohemagglutinins and complement-3 levels in patients with thalassemia major.

Authors:  C Vergin; N Kutukculer; N Cetingul; G Nisli; S Caglayan; S Oztop
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

2.  Function of reticuloendothelial system in splenectomised thalassemics.

Authors:  A Germenis; P Dimitriou; H Vrettou; C Politi; T H Karpathios; S E Antipas
Journal:  Blut       Date:  1988-11

3.  Elevated polymorphonuclear phagocytic function in thalassemia patients by chemiluminescence.

Authors:  S S Deo; S M Merchant; A C Kapadia
Journal:  Indian J Pediatr       Date:  1994 Jul-Aug       Impact factor: 1.967

4.  Inhibition of cell-free oxidative bactericidal activity by erythrocytes and hemoglobin.

Authors:  W L Hand
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Plasma fibronectin (Fn) study in homozygous beta-thalassemia: relation to splenectomy and transfusion.

Authors:  A Germenis; G Peppas; C Politi; A Fertakis
Journal:  Blut       Date:  1984-08

6.  Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.

Authors:  J T Mayes; R D Schreiber; N R Cooper
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.